Trial Profile
Multicenter study for anti-oxidative and anti-inflammatory effects of pitavastatin in hypercholesterolemic patients with metabolic syndrome.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary)
- Indications Hypercholesterolaemia; Metabolic syndrome
- Focus Therapeutic Use
- 23 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 10 Nov 2007 Status changed from initiated to recruiting.
- 02 May 2007 New trial record.